13 MAY 2004

NEW ZEALAND GAZETTE, No. 52

1285

Health

Burial and Cremation Act 1964

Interpretation Act 1999

Closure of the Church of England Burial Ground, Rangiora

Pursuant to section 41 (1) of the Burial and Cremation Act 1964 and section 15 of the Interpretation Act 1999, I, Graeme Gillespie, Manager, Public Health Programmes, acting under delegation from the Minister of Health, hereby:

1. Amend the conditions to the closing of the denominational burial ground known as the Church of England Burial Ground, Rangiora (“the ground”) and published in the New Zealand Gazette, 2 September 1999, No. 108, page 2599, notice No. 6334 (“closure notice”), as follows.

2. This closure notice is subject to the following amended conditions:

   (a) The front portion of the ground fronting Ashley Street, Rangiora, and described as Lot 1 on DP 326832, containing 9376 square metres, being part of the land in Computer Register CB35C/779, will continue to be used for burials as set out in the original Notice of Consecration attached to the closure notice.

   (b) The remaining portion of the ground (other than the portion described in condition 2 (a) above) fronting Edward Street, Rangiora, and described as Lots 2-12 inclusive on DP 326832, containing 1.0488 hectares, being the balance of the land in Computer Register CB35C/779, is excluded from section 42 and section 44 (4) of the Burial and Cremation Act 1964 and, accordingly, that portion may be subdivided and sold.

Dated at Wellington this 10th day of May 2004.

GRAEME GILLESPIE, Manager, Public Health Programmes.

go3074

Medicines Act 1981

Corrigendum—Provisional Consent to the Distribution of a New Medicine

In the notice published in the New Zealand Gazette, 18 December 2003, No. 173, page 4770, the entry in lines 11 to 20 for Thalidomide Pharmion capsule is deleted and the following substituted:

Schedule

Product: Thalidomide Pharmion

Active Ingredient: Thalidomide 50mg

Dosage Form: Capsule

New Zealand Sponsor: Douglas Pharmaceuticals Limited

Manufacturer: Penn Pharmaceuticals Limited, Tredegar, Gwent, United Kingdom

Note: This consent is given subject to the following conditions:

● Only members of the Royal Australasian College of Physicians can prescribe Thalidomide.

● Douglas Pharmaceuticals Limited will manage the risk management programme relating to the distribution and use of thalidomide.

Also Note: This consent is valid for two years from the date of publication of the original notice (18 December 2003).

Dated this 5th day of May 2004.

DAVID NICHOLSON, National Services Manager, acting as Deputy Director-General, Public Health for the period 5 May 2004 to 28 May 2004 (pursuant to delegation given by the Minister of Health on the 6th day of July 2001).

go3086

Renewal of Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product: Fasturtec

Active Ingredient: Rasburicase 1.5mg

Dosage Form: Powder for infusion

New Zealand Sponsor: Pharmacy Retailing (NZ) Limited

Manufacturer: Sanofi Winthrop Industrie, Notre Dame de Bondeville, France

Note: This consent is valid for two years from 1 August 2004.

Dated this 2nd day of May 2004.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on the 6th day of July 2001).

go2962